
To date, infections have been reported in four states:
- Pennsylvania, with 20 identified cases;
- Maryland, with 11 cases;
- Delaware, with three cares; and
- New Jersey, with two cases.
As the U.S. Centers for Disease Control and Prevention (CDC) notes, symptoms of B. cepacia infection vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with cystic fibrosis. B. cepacia can also be resistant to many common antibiotics.
The recall applies to flush syringes with 3ml, 5ml and 10 ml fills across four product codes. These lots were distributed between February 16 and September 30 of this year.
To return recalled product for credit, contact Nurse Assist customer service at (800) 649-6800 ext. 10.